Labshake search
Citations for R&D Systems :
301 - 350 of 1889 citations for MIF Macrophage migration inhibitory factor Mouse His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... and differentiated in complete monocyte derived macrophage (MDM) medium containing 10 ng/ml M-CSF (R&D Systems, Abingdon, UK) for two days ...
-
bioRxiv - Microbiology 2020Quote: ... macrophages were infected with AsaiapHM4 in presence of Escherichia coli lipopolysaccharide (LPS) (0.3 μg/ml) (R&D Systems, Minneapolis, MN). After a 10 min centrifugation at 1,000 rpm ...
-
bioRxiv - Microbiology 2023Quote: ... THP-1 cells were first differentiated into macrophages with 50 nM Phorbol-12-Myristate-13-Acetate (PMA) (R&D systems) for 72 hrs ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and Alexa Fluor 647® (AF647)-conjugated anti-His antibody (R&D Systems, catalog # IC0501R) or HER2-ED (R&D Systems ...
-
bioRxiv - Microbiology 2020Quote: ... THP-1 cells were differentiated into macrophages and dendritic cells using 50 ng/ml GM-CSF (R&D Systems, https://www.rndsystems.com) + 50 ng/ml M-CSF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... Macrophage differentiation from bone marrow cells was obtained by culture in standard growth medium supplemented with m-CSF (R&D Systems) at 30 ng/ml for 7 days.
-
bioRxiv - Immunology 2022Quote: ... and TNF levels were determined in the supernatants of Calu-3 and macrophage cultures using ELISA kits following the manufacturer’s instructions (R&D Systems). HMGB-1 was determined in the cell-free TA supernatants and in the supernatants of Calu-3 cultures using immunoassay following the manufacturer’s instructions (Novus Biologicals) ...
-
bioRxiv - Microbiology 2023Quote: Harvested supernatants from infected human macrophages were assayed for cytokine levels using ELISA kits for human IL-1α (R&D Systems), IL-18 (R&D Systems) ...
-
bioRxiv - Neuroscience 2021Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). The MN culture medium was replaced every other day for 6 days and the MN cultures were characterized by immunocytochemistry as described below ...
-
bioRxiv - Cell Biology 2019Quote: ... Q-VD-OPh and Tumor Necrosis Factor-alpha (TNFα) were obtained from R&D Systems. Ionomycin was purchased from Calbiochem ...
-
bioRxiv - Neuroscience 2020Quote: ... with addition of pen/strep and growth factor bFGF 10 ng/ml (R&D Systems). Medium was changed every third day and cells were enzymatically passaged using Accutase (Gibco) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 μM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Systems Biology 2020Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 µM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Bioengineering 2019Quote: ... and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems, Minneapolis, MN) (39 ...
-
bioRxiv - Developmental Biology 2019Quote: ... goat anti-Platelet derived growth factor receptor beta (PDGFRB, 1:1000, AF1042, R&D systems), rat anti-Plasmalemma vesicle associated protein (PLVAP ...
-
bioRxiv - Neuroscience 2020Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050) for 6 days before single cell suspension preparation.
-
bioRxiv - Neuroscience 2021Quote: ... or 10 ng/mL recombinant rat platelet-derived growth factor (PDGF-aa) (R&D Systems) and 10 ng/mL FGF-2 (Peprotech ...
-
bioRxiv - Developmental Biology 2021Quote: ... goat anti-platelet derived growth factor receptor-beta (PDGFRB, 1:1000, AF1042, R&D Systems), goat anti-notch3 (NOTCH3 ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng ml−1 basic fibroblast growth factor (FGF2; R&D Systems, 233-FB) for 16 d ...
-
bioRxiv - Neuroscience 2024Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). Culture medium was replaced every other day for 6 days and the resulting MNs were characterized by immunocytochemistry ...
-
bioRxiv - Neuroscience 2024Quote: ... and basic fibroblast growth factor (bFGF, 20 ng ml-1, R&D Systems, 233-FB) until day 24 ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml of brain-derived neurotrophic factor (BDNF; 248-BDB-010, R&D Systems), and 10 ng/ml of glia cell line-derived neurotrophic factor (GDNF ...
-
bioRxiv - Cell Biology 2024Quote: ... and 10 ng/ml keratinocyte growth factor (R&D Systems Cat#251KG, Minneapolis, MN, USA). RHEs were cultured for ten additional days with media being changed every 2-3 days.
-
bioRxiv - Neuroscience 2020Quote: Primary antibodies for immunoprecipitation and Western blotting included anti-V5 and anti-His (R&D systems), Mouse anti-VAMP2 (SySy Synaptic Systems ...
-
bioRxiv - Microbiology 2021Quote: Monocyte-derived macrophages (MDMs) were obtained by stimulation of PBMC cultures with 15 ng/mL recombinant human M-CSF (R&D systems) and 10% human AB serum (Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: Mature macrophages (n = 6 donors) were stimulated for 48 hours with complete medium containing IFN-γ (20 ng/mL, R&D Systems) and LPS (100 ng/mL ...
-
bioRxiv - Microbiology 2022Quote: ... Using density gradient medium (Lymphoprep) monocytes were isolated and differentiated into macrophages in the presence of GM-CSF (100 ng/mL) (R&D Systems) in 1640 RPMI + 5% FBS +P/S media for 6 to 7 days
-
bioRxiv - Immunology 2020Quote: ... IL-8 and TNF from SP140 siRNA or scrambled-treated M1 macrophages (LPS-stimulated or unstimulated) were determined by Sandwich Enzyme-Linked Immunosorbent Assay (ELISA; R&D systems) according to manufacturer’s protocol.
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Bioengineering 2023Quote: ... The classical monocytes were isolated using biotin-conjugated antibodies and streptavidin-conjugated magnetic beads to deplete labeled cells and were then conditioned into resting macrophages (M0) using RPMI 1640 supplemented with 10% fetal bovine serum (FBS, S11150H, R&D Systems) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Cell Biology 2023Quote: We measured levels of secreted IL-10 in supernatants from infected or non-infected human primary macrophages cells using commercially available enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems) according to the manufacturers’ instructions.
-
bioRxiv - Microbiology 2023Quote: ... anti-hCD14 magnetic beads were used and isolated cells were differentiated to human monocyte-derived macrophages (hMDMs) by addition of 50 ng/ml rhM-CSF (R&D Systems) to XVivo medium (Lonza) ...
-
bioRxiv - Neuroscience 2020Quote: ... and goat anti-platelet derived growth factor receptor-alpha (PDGFRα, R&D systems #AF1062, 1:200), in a PBS-based diluent buffer containing 10% normal donkey serum and 0.2% Triton-X100 ...
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant epidermal growth factor (10 ng/ml; Cat#236-GMP-200, R&D Systems, USA). Cells at 70-80% confluency were harvested and total cell counts were obtained ...
-
bioRxiv - Bioengineering 2020Quote: ... recombinant basic fibroblast growth factor (10 ng/ml; Cat#233-GMP-025, R&D Systems, USA) and recombinant epidermal growth factor (10 ng/ml ...
-
bioRxiv - Molecular Biology 2021Quote: ... epidermal growth factor (EGF, 20 ng/mL, Cat. #236-EG; R&D Systems, Minneapolis, MN, USA), basic fibroblast growth factor (bFGF ...
-
bioRxiv - Physiology 2021Quote: ... supplemented with bovine pituitary extract and epidermal growth factor (EGF) (R&D Systems, Minneapolis, MN, USA), 10−10 molL-1 cholera toxin (Calbiochem ...
-
bioRxiv - Physiology 2021Quote: ... 1% P/S antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (BAF322 R&D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... and 2.5 ng/µl of recombinant human fibroblast growth factor (R&D systems, Minneapolis, MN, USA), and cultured at 37°C in a humidified atmosphere of 5% CO2 in air ...
-
bioRxiv - Neuroscience 2023Quote: ... and human fibroblast growth factor 2 (hFGF2) (20 ng/mL, R&D systems 233-FB-025) freshly added into the media ...
-
bioRxiv - Cell Biology 2022Quote: ... but supplemented with 30ng/μl tumor necrosis factor alpha (TNFα; R&D systems, #210-TA-020) for 7d ...
-
bioRxiv - Cell Biology 2023Quote: ... 20 ng/mL glial cell line-derived neurotrophic factor (GDNF; R&D systems, catalog #: 212-GD), and 10 µM ROCK inhibitor Y27632 (HelloBio ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... stimulation with transforming growth factor β (TGF-β, 240-B, R&D Systems, Minneapolis, MN, USA), dissolved in 0.1% (weight/volume [w/v] ...
-
bioRxiv - Genomics 2024Quote: ... 70% Feeder-CM plus 30% TS medium (70cond) supplemented with growth factor FGF4 (R&D System) and heparin (Sigma ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2 ng/ml glial cell-derived neurotrophic factor (GDNF, R&D Systems, Minneapolis, MN, USA). The experiments were conducted on flasks or multi-well plates (Nunc ...